EQL Pharma AB (FRA:7JK) ROE % Adjusted to Book Value : 1.70% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB ROE % Adjusted to Book Value?

EQL Pharma AB's ROE % for the quarter that ended in Mar. 2024 was 10.65%. EQL Pharma AB's PB Ratio for the quarter that ended in Mar. 2024 was 6.28. EQL Pharma AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 1.70%.

EQL Pharma AB ROE % Adjusted to Book Value Historical Data

The historical data trend for EQL Pharma AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB ROE % Adjusted to Book Value Chart

EQL Pharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

3.72

3.06

2.17

EQL Pharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															1.52	3.24	2.60	3.01	1.70

Competitive Comparison of EQL Pharma AB's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EQL Pharma AB's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's ROE % Adjusted to Book Value falls into.

EQL Pharma AB ROE % Adjusted to Book Value Calculation

EQL Pharma AB's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	13.60%	/	6.28
	=	2.17%

EQL Pharma AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	10.65%	/	6.28
	=	1.70%

EQL Pharma AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

EQL Pharma AB (FRA:7JK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

EQL:Sweden

Address

Stortorget 1, 3rd Floor, Lund, SWE, 222 23

Website

http://www.eqlpharma.com

EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (FRA:7JK) Headlines

No Headlines